Biweekly versus standard Cisplatin and Gemcitabine for Elderly Patients with Advanced Biliary Tract Cancer (BCG65), a randomized-controlled trial

Authors
Category Primary study
Registry of TrialsThai Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: 46e52a9c9847bc34e02ed3fd0096ff09a6cee140
First added on: Apr 24, 2026